A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

NCT00420849 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

587

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Celgene Corporation